Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Processa Pharmaceuticals Inc PCSA

Healthcare
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on utilizing its regulatory science approach, including the principles associated with food and drug administration (FDA’s) Project Optimus Oncology initiative and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy (NGC) oncology drug products. The three NGC... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PCSA)

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference

GlobeNewswire 11 days ago

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

GlobeNewswire April 30, 2024

Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial

GlobeNewswire April 11, 2024

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

GlobeNewswire March 28, 2024

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

GlobeNewswire March 25, 2024

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

GlobeNewswire February 21, 2024

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

GlobeNewswire February 14, 2024

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

GlobeNewswire February 6, 2024

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering

GlobeNewswire February 1, 2024
View More News ››

Opinion & Analysis (NDAQ:PCSA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PCSA)

Processa Pharmaceuticals to Participate in the EF Hutton Ann

NEWS: $PCSA Processa Pharmaceuticals to Participate in the EF Hutton Annual Global ConferenceHANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE)...
whytestocks - 11 days ago

US Companies Moving the Markets, Morning edition <br>Thu, Ap

BREAKING NEWS: $PCSA US Companies Moving the Markets, Morning edition Thu, Apr 25, 2024 as of 10.00 am ETA look at the top 10 most...
whytestocks - April 25, 2024

InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ:

News; $PCSA InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $7M Public OfferingProcessa Pharmaceuticals...
whytestocks - February 2, 2024

What's Going On With Anti Cancer Focused Processa Pharmaceut

News; $PCSA What's Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today? | BenzingaThursday,@Processa...
whytestocks - January 26, 2024

RE:RE:RE:RE:PCSA..... go ahead .... I dare ya to Chase !

JUst to be perfectly clear..... I was wrong about my AH prediction on PCSA.....It actually went alot higher than I thought it would....my...
Iseneschal - January 26, 2024

PCSA....Well...well...well. What do ya know?

  Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering   2024-01-26 06:04 ET - News Release...
Iseneschal - January 26, 2024
View more Bullboard ››

Nicola Mining Inc

Nicola Mining Inc

Nicola Mining Inc. is a Canada-based junior mining company. The Company maintains a 100% owned mill and tailings facility ...
View More »